Trial Profile
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pafolacianine (Primary)
- Indications Renal cell carcinoma
- Focus Diagnostic use
- 19 Dec 2019 Status changed from recruiting to completed.
- 26 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 2 Apr 2018.
- 08 Jan 2016 New trial record